Name of Company: Medrobotics Corp.
Industry: Medical devices
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Location: Raynham, Massachusetts
Solution/Product: Flexible medical robots that allow “single-site access and visualization to difficult to reach anatomy.”
Money Raised: $8.1 million; seeking another $11.9 million through a convertible note offering; money raised, excluding this round is $28.3 million in preferred equity financing
How it will be used: Unknown, president and CEO did not return a call.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Investors: Pittsburgh Life Sciences Greenhouse, angel investors
Management team: Samuel Straface, President & CEO; Mark Peters, CFO and Treasurer;
Market size: The company aims to pursue several markets – minimally invasive cardiac surgery, electrophysiology, natural orifice and a range of single-port laparoscopic and thoracoscopic procedures – and the market size is unknown.
Competitors: Hansen Medical also makes medical flexible robots.
